Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Pharmacological Reports : PR|March 17, 2025
Polypharmacology: new drugs in 2023-2024Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports : PR|June 6, 2023
Polypharmacology: promises and new drugs in 2022Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Antioxidants (Basel, Switzerland)|April 29, 2025
Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?Piotr Ryszkiewicz, Eberhard Schlicker, Barbara Malinowska
Pharmacological Reports : PR|July 22, 2026
Multi-target-directed drugs: new additions in 2025 and post-marketing safety surveillance of drugs marketed in 2022-2024Piotr Ryszkiewicz, Marta Baranowska-Kuczko, Barbara Malinowska, et al.
International Journal of Molecular Sciences|July 14, 2023
Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve AnalysisMarek Toczek, Piotr Ryszkiewicz, Patryk Remiszewski, et al.
British Journal of Pharmacology|May 26, 2004
Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed ratsGrzegorz Godlewski, Barbara Malinowska, Eberhard Schlicker
British Journal of Pharmacology|October 26, 2011
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?Barbara Malinowska, Marta Baranowska-Kuczko, Eberhard Schlicker
Pageof 10